Антифосфолипидный синдром - Насонов Е.Л.
ISBN 5-98216-010-5
Скачать (прямая ссылка):
171. Asherson RA, Hughes GRV. Hypoadre-nalism, Addison's disease and antiphospholipid antibodies. J Rheumatol 1991; 18: 1—3.
172. Asherson RA. Hypoadrenalism and the antiphospholipid antibodies. A new cause of idio-pathic "Addison's disease". In: Bhatt, James, Besser, Botazzo, Keen (eds): Advances in Thomas Addison's diseases. Vol. 1. J Endocrinol Ltd. Bristol. 1994; 87—101.
173. Arnason JA, Graziano FM. Adrenal insufficiency in the antiphospholipid antibody syndrome. Semin Arthritis Rheum 1995; 25: 109—116.
174. Pelkonen P, Simell O, Rasi V, et al. Venous thrombosis associated with the lupus anticoagulant. Ann Intern Med 1980; 92: 156—159.
175. Grottolo A, Ferrari V, Mariarosa M, et al. Primary adrenal insufficiency, circulating Lupus
SHS-OOO4.qxd 21.11.2006 16:56 Page 2 02"
02
Насонов Е.Л. Антифосфолипидный синдром.
Anticoagulant and anticardiolipin antibodies in a patient with multiple abortions and recurrent thrombotic episodes. Haematologia 1988; 73: 517—519.
176. Asherson RA, Hughes GRV. Recurrent deep vein thrombosis in Addison's disease in "primary" antiphospholipid syndrome. J Rheumatol 1989; 16: 378—380. Carette S, Jobin F. Acute adrenal insufficiency as a manifestation of the anticardiolipin syndrome. Ann Rheum Dis 1989; 48: 430—431.
177. Rao R, Vagnucci A, Amico J. Bilateral massive adrenal haemorrhage: Early recognition and treatment. Ann Intern Med 1989; 110: 227—235.
178. Marie I, Levesque H, Heron F, Kailleux N, Borg JY, Courtois H. Acute adrenal failure secondary to bilateral infarction of the adrenal glands as the first manifestation of primary antiphospholipid antibody syndrome. Ann Rheum Dis 1997; 567—568.
179. Argento A, Di Benedetto RJ. ARDS and adrenal insufficiency associated with the antiphospholipid antibody syndrome. Chest 1998; 113: 1136—1138.
180. Guibal F, Rybojad M, Cordoliani F, et al. Melanoderma revealing primary antiphospholipid syndrome. Dermatol 1996; 192: 75—77.
181. Provenzale JM, Ortel TL, Nelson RC. Adrenal haemorrhages in patients with primary antiphospholipid syndrome: Imaging findings. Am J Roentgenol 1995; 165: 361—364.
182. Oelkers W. Adrenal insufficiency IV. N Engl J Med 1996; 335: 1206—1212.
183. Pomeroy C, Knodell RG, Swain WR, Arneson P, Mahowald ML. Budd-Chiari syndrome in a patient with the lupus anticoagulant. Gastroenterology 1984; 86: 158—161.
184. Shimizu S, Miyata M, Kamiike W, et al. Budd-Chiari syndrome combined with antiphos-pholipid syndrome: Case report and literature review. Vasc Surg 1993; 501—509.
185. Farrant JM, Judge M, Thompson RDH. Thrombotic cutaneous nodules and hepatic vein thrombosis in the anticardiolipin syndrome. Clin Exp Dermatol 1989; 14: 306—308.
186. Ouwendijk RJT, Koster JC, Wilson JHP, et al. Budd-Chiari syndrome in a young patient with anticardiolipin antibodies: Need for prolonged anticoagulant treatment. Gut 1994; 35: 1004—1006.
187. Mackworth-Young CG, GharaviAE, Boey ML, Hughes GRV. Portal and pulmonary hypertension in a case of systemic lupus erythematosus: Possible relationship with a clotting abnormality. Eur JRheum Inflam 1984; 7: 71—74.
188. Ordi J, Vargas V, Vilardell M, et al. Lupus anticoagulant and portal hypertension. Am J Med 1988; 84: 566—568.
189. De Clerck L, Michielsen PP, Ramael MR, et al. Portal and pulmonary vessel thrombosis associated with systemic lupus erythematosus and anticardiolipin antibodies. JRheumatol 1991; 18: 1919—1921.
190. Takahaski C, Kumagai S, Tsubata R, et al. Portal hypertension associated with anticardi-olipin antibodies in case of systemic lupus eErythematosus. Lupus 1995; 4: 232—235.
191. Mantz FA, Craige E. Portal axis thrombosis with spontaneous portacaval shunt and resultant cor pulmonale. Arch Pathol 1951; 52:91—97.
192. Nakamura H, Uehara H, Okada T, et al. Occlusion of small hepatic veins associated with systemic lupus erythematosus with the lupus anticoagulant. Hepatogastroenterol 1989; 36: 393— 397.
193. Morio S, Oh H, Hirasawa A, et al. Hepatic veno-occlusive disease in a patient with lupus anticoagulant after allogeneic bone marrow transplantation. Bone Marrow Transplant 1991; 8: 147—149.
194. Morle RM, Ramos-Casals M, Garcia-Carrasco M, et al. Nodular regenerative hyper-plasia of the liver and antiphospholipid antibodies: report of two cases and review of the literature. Lupus 1999; 8:160—163.
195. Rio B, Andreu G, Nicod A, et al. Thrombocytopenia in veno-occlusive disease after bone marrow transplantation or chemotherapy. Blood 1986; 67: 1773—1776.
196. Perez—Ruiz F, Orte-Martinez FJ, Zea-Mendoza AC, Ruiz del Arbol L, Moreno-Caparras A. Nodular regenerative hyperplasia of the liver in rheumatic diseases: report of seven cases and review of the literature. Semin Arthritis Rheum 1991; 21: 47—54.
197. Mor T, Beigel Y, Inbal A, Goren M, Wysenbeek A G. Hepatic infarction in a patient with the lupus anticoagulant. Arthritis Rheum 1989; 32: 491—495.
SHS-OOO4.qxd 21.11.2006 16:56 Page 2 003
ГЛАВА 7. Клинические проявления антифосфолипидного синдрома
